Content about Melanoma

April 8, 2014

L’Oréal Paris and the Melanoma Research Alliance, a private funder of melanoma research, have announced the launch of the “It’s THAT Worth It” campaign, a public health call-to-action that urges women of all skin tones to prevent melanoma by using sunscreen and to help save lives by supporting melanoma research for a cure.

NEW YORK — L’Oréal Paris and the Melanoma Research Alliance, a private funder of melanoma research, have announced the launch of the “It’s THAT Worth It” campaign, a public health call-to-action that urges women of all skin tones to prevent melanoma by using sunscreen and to help save lives by supporting melanoma research for a cure.

March 14, 2014

Legislation introduced to unclog the backlog of sunscreen ingredients and streamline the review process for faster public access has garnered the accolades of the Public Access to SunScreen Coalition.

WASHINGTON — Legislation introduced to unclog the backlog of sunscreen ingredients and streamline the review process for faster public access has garnered the accolades of the Public Access to SunScreen Coalition.

January 20, 2014

The Food and Drug Administration recently approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (i.e., cannot be removed by surgery) or metastatic (i.e., late-stage), Onco360 announced last week.

NEW YORK — The Food and Drug Administration recently approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (i.e., cannot be removed by surgery) or metastatic (i.e., late-stage), Onco360 announced last week. 

Both Mekinist and Tafinlar are only available in limited distribution, and Onco360 is one of the few pharmacies with access to both medications.

January 10, 2014

The Food and Drug Administration has approved two drugs made by GlaxoSmithKline for use together in patients with advanced melanoma that can't be removed by surgery or has spread to other parts of the body, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved two drugs made by GlaxoSmithKline for use together in patients with advanced melanoma that can't be removed by surgery or has spread to other parts of the body, the agency said Friday.

The FDA announced the new approval for Mekinist (trametinib) and Tafinlar (dabrafenib). The agency originally approved the two drugs for use as single agents for the same indication in May 2013.

October 11, 2013

The Skin Cancer Foundation’s annual Road to Healthy Skin Tour, presented by Rite Aid, has wrapped up its sixth cross-country journey, bringing free skin cancer screenings and prevention information to communities across America.

NEW YORK — The Skin Cancer Foundation’s annual Road to Healthy Skin Tour, presented by Rite Aid, has wrapped up its sixth cross-country journey, bringing free skin cancer screenings and prevention information to communities across America.

During this year’s tour, volunteer dermatologists detected 788 suspected pre-cancers and cancers, including 29 suspected melanomas.

July 24, 2013

Canadian regulators have approved two drugs made by GlaxoSmithKline for treating skin cancer.

MISSISSAUGA, Ontario — Canadian regulators have approved two drugs made by GlaxoSmithKline for treating skin cancer, GSK said Wednesday.

The drug maker announced Health Canada's approval of Tafinlar (dabrafenib mesylate) and Mekinist (trametinib) in patients with melanoma that can't be removed by surgery or has spread to other parts of the body.

May 28, 2013

Looking to spread the word about the dangers of sun exposure and recommit to taking preventive measures like wearing sunscreen, Jergens is promoting its Natural Glow Daily Moisturizer, which has been reformulated with odor-reducing technology.

NEW YORK — Looking to spread the word about the dangers of sun exposure and recommit to taking preventive measures like wearing sunscreen, Jergens is promoting its Natural Glow Daily Moisturizer, which has been reformulated with odor-reducing technology.

May 20, 2013

Energizer Personal Care, which makes Banana Boat and Hawaiian Tropic brand sunscreens, has teamed up with the Skin Cancer Foundation to launch a public awareness campaign featuring Los Angeles Galaxy and Team USA soccer player Landon Donovan.

SHELTON, Conn. — Energizer Personal Care, which makes Banana Boat and Hawaiian Tropic brand sunscreens, has teamed up with the Skin Cancer Foundation to launch a public awareness campaign featuring Los Angeles Galaxy and Team USA soccer player Landon Donovan.

The awareness campaign is the second part of a two-year effort aimed at encouraging men to incorporate sun protection into their daily lives.

May 6, 2013

In recognition of "Melanoma Monday," L'Oréal Paris has released a new survey on melanoma awareness and prevention among women of all skin tones, and announced a philanthropic alliance with the Melanoma Research Alliance.

NEW YORK — In recognition of "Melanoma Monday," L'Oréal Paris has released a new survey on melanoma awareness and prevention among women of all skin tones, and announced a philanthropic alliance with the Melanoma Research Alliance.

May 6, 2013

Rite Aid is sending out a customized 38-ft. van to 50 stores around the country as part of a campaign to promote skin care.

CAMP HILL, Pa. — Rite Aid is sending out a customized 38-ft. van to 50 stores around the country as part of a campaign to promote skin care.

The retail pharmacy chain announced Monday the start of the Road to Healthy Skin Tour, which it is sponsoring on behalf of the Skin Cancer Foundation to coincide with Skin Cancer Awareness Month. The tour is in its sixth year and will visit Rite Aid stores in the Northeast, Midwest, South and West.

February 21, 2013

Less than one-quarter of American adults have ever had a skin check by a dermatologist despite rising rates of skin cancer, according to a new survey.

IRVINGTON, N.Y. — Less than one-quarter of American adults have ever had a skin check by a dermatologist despite rising rates of skin cancer, according to a new survey.

February 14, 2013

Mustela, a European skin care and stretch marks brand, recently introduced three products in a sun care range for babies.

NEW YORK — Mustela, a European skin care and stretch marks brand, recently introduced three products in a sun care range for babies.

The new Broad Spectrum SPF 50+ Mineral Sunscreen Lotion and Broad Spectrum SPF 50+ Mineral Sunscreen Stick are tested under the most recent FDA requirements for sunscreen and have both been awarded the Melanoma International Foundation’s Seal of Approval, the company stated.


Mustela’s formulations are 100% mineral, with naturally derived sunscreen filters titanium dioxide and zinc oxide.



October 26, 2012

A Swiss subsidiary of drug maker Celgene Corp. said its chemotherapy drug produced "significant" improvement in progression-free survival in patients with a deadly skin cancer that had spread elsewhere in the body.

BOUDRY, Switzerland — A Swiss subsidiary of drug maker Celgene Corp. said its chemotherapy drug produced "significant" improvement in progression-free survival in patients with a deadly skin cancer that had spread elsewhere in the body.

October 17, 2012

A cancer drug made by Bristol-Myers Squibb has received an award from Galien Foundation, the drug maker said Wednesday.

PRINCETON, N.J. — A cancer drug made by Bristol-Myers Squibb has received an award from Galien Foundation, the drug maker said Wednesday.

The company said Yervoy (ipilimumab) received the 2012 Prix Galien USA Prize in the Best Biotechnology Product category. Yervoy — used to treat melanoma that has spread to other parts of the body, known as metastasis — is the first new drug for melanoma that is metastatic or can't be removed through surgery in more than a decade.

August 6, 2012

Neutrogena and actress Gabrielle Union are urging people to make skin cancer prevention part of their daily, year-round routines on the heels of a recent national survey that found just 13% of all women in the United States wear sunscreen on a daily basis.

LOS ANGELES — Neutrogena and actress Gabrielle Union are urging people to make skin cancer prevention part of their daily, year-round routines on the heels of a recent national survey that found just 13% of all women in the United States wear sunscreen on a daily basis.

July 16, 2012

During the summer months, sun protection obviously is top of mind for many, especially among those with lighter skin who easily burn. However, there likely are shoppers in your store who have the misconception that their darker skin makes them immune to skin cancer and the harmful effects of the sun.


During the summer months, sun protection obviously is top of mind for many, especially among those with lighter skin who easily burn. However, there likely are shoppers in your store who have the misconception that their darker skin makes them immune to skin cancer and the harmful effects of the sun.


Educating consumers — especially those with darker skin — of the risks not only will help bolster sales of sunscreens but, more importantly, can help save lives.


June 20, 2012

Men older than 50 years of age are more than twice as likely as women to develop and die from melanoma, yet many men admit to not using sunscreen, and even more report not knowing what skin cancer warning signs to look for, according to the results of a survey released by the Skin Cancer Foundation in partnership with the makers of Banana Boat and Hawaiian Tropic brand sunscreens.

SHELTON, Conn. — Men older than 50 years of age are more than twice as likely as women to develop and die from melanoma, yet many men admit to not using sunscreen, and even more report not knowing what skin cancer warning signs to look for, according to the results of a survey released by the Skin Cancer Foundation in partnership with the makers of Banana Boat and Hawaiian Tropic brand sunscreens.

June 13, 2012

Beauty company L'Oréal is working to increase awareness that just because a person's skin may be darker in color does not mean he or she is immune to skin cancer.

NEW YORK — Beauty company L'Oréal is working to increase awareness that just because a person's skin may be darker in color does not mean he or she is immune to skin cancer.

May 15, 2012

A former football coach is joining an effort to educate men about the risks of a deadly form of skin cancer.

NEW YORK — A former football coach is joining an effort to educate men about the risks of a deadly form of skin cancer.

Former National Football League Pittsburgh Steelers coach Bill Cowher will work with Melanoma Exposed, an educational campaign run by the Melanoma International Foundation, Melanoma Research Alliance, Melanoma Research Foundation and the Skin Cancer Foundation, with sponsorship from drug maker Bristol-Myers Squibb, the organizations announced Tuesday.

May 9, 2012

The Skin Cancer Foundation's Road to Healthy Skin Tour, presented by Aveeno and Rite Aid, once again is touring the country to raise skin cancer awareness.

SKILLMAN, N.J. — The Skin Cancer Foundation's Road to Healthy Skin Tour, presented by Aveeno and Rite Aid, once again is touring the country to raise skin cancer awareness.

This year, the Aveeno brand is hitting the road in the tour's customized RV to make an estimated 85 stops in 27 states from March through September. It will provide free full-body skin cancer screenings, samples of Aveeno products and educational materials.

March 22, 2012

Rite Aid is sponsoring skin cancer screenings at dozens of stores across the country as part of a tour that begins this month and ends in August, the retail pharmacy chain said Thursday.

CAMP HILL, Pa. — Rite Aid is sponsoring skin cancer screenings at dozens of stores across the country as part of a tour that begins this month and ends in August, the retail pharmacy chain said Thursday.

Rite Aid said the Skin Cancer Foundation would travel across the country in a 38-ft. RV to more than 50 Rite Aid locations as part of the Road to Healthy Skin Tour, which Aveeno also is co-sponsoring, starting this week.

December 21, 2011

Skin care brand La Roche-Posay is partnering with Mollie's Fund, the Mollie Biggane Melanoma Foundation, in its mission to increase awareness for melanoma prevention.

NEW YORK — Skin care brand La Roche-Posay is partnering with Mollie's Fund, the Mollie Biggane Melanoma Foundation, in its mission to increase awareness for melanoma prevention.

Touched by the Mollie Biggane story — the college sophomore was diagnosed with melanoma and died at age 20 — La Roche-Posay is donating 10,000 full-size pieces of its Anthelios 45 ultra light sunscreen fluid to cancer patients who currently are undergoing treatment and are at high risk because of compromised immune systems.

August 17, 2011

The Food and Drug Administration has approved a new drug and companion diagnostic test for the most dangerous type of skin cancer, the agency said Wednesday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug and companion diagnostic test for the most dangerous type of skin cancer, the agency said Wednesday.

The FDA announced the approval of Genentech's and Daiichi Sankyo's Zelboraf (vemurafenib), for patients with late-stage melanoma that can't be removed by surgery. Genentech is the U.S. division of Swiss drug maker Roche.

June 2, 2011

Bristol-Myers Squibb will collaborate with Roche to investigate the use of a combination of the companies’ drugs in patients with a deadly form of skin cancer.

NEW YORK — Bristol-Myers Squibb will collaborate with Roche to investigate the use of a combination of the companies’ drugs in patients with a deadly form of skin cancer.

The companies will conduct a phase 1/2 trial to test the safety and efficacy of BMS’ Yervoy (ipilimumab) in combination with Roche’s investigational drug vemurafenib in patients with melanoma that has spread to other parts of the body.

May 11, 2011

Genentech is seeking approval for a new drug to treat skin cancer, the company said Wednesday.

SOUTH SAN FRANCISCO, Calif. — Genentech is seeking approval for a new drug to treat skin cancer, the company said Wednesday.